Literature DB >> 21724673

Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.

Marc J Fishman1, Li-Tzy Wu, George E Woody.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21724673      PMCID： PMC3178807          DOI： 10.1176/appi.ajp.2010.10060879

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  36 in total

Review 1.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

Authors:  Lynn E Sullivan; Marek Chawarski; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2005-07       Impact factor: 4.492

3.  Intravenous buprenorphine self-administration by detoxified heroin abusers.

Authors:  Sandra D Comer; Eric D Collins; Marian W Fischman
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

4.  Clinical pharmacology of buprenorphine: ceiling effects at high doses.

Authors:  S L Walsh; K L Preston; M L Stitzer; E J Cone; G E Bigelow
Journal:  Clin Pharmacol Ther       Date:  1994-05       Impact factor: 6.875

5.  How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Dan G Blazer
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

6.  Naltrexone pharmacotherapy for opioid dependent federal probationers.

Authors:  J W Cornish; D Metzger; G E Woody; D Wilson; A T McLellan; B Vandergrift; C P O'Brien
Journal:  J Subst Abuse Treat       Date:  1997 Nov-Dec

7.  Effects of major depression on remission and relapse of substance dependence.

Authors:  Deborah Hasin; Xinhua Liu; Edward Nunes; Steven McCloud; Sharon Samet; Jean Endicott
Journal:  Arch Gen Psychiatry       Date:  2002-04

8.  Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders.

Authors:  Efrat Aharonovich; Xinhua Liu; Edward Nunes; Deborah S Hasin
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

9.  A new series of 13 buprenorphine-related deaths.

Authors:  Pascal Kintz
Journal:  Clin Biochem       Date:  2002-10       Impact factor: 3.281

10.  Six deaths linked to concomitant use of buprenorphine and benzodiazepines.

Authors:  M Reynaud; G Petit; D Potard; P Courty
Journal:  Addiction       Date:  1998-09       Impact factor: 6.526
View more
  3 in total

Review 1.  Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Authors:  Paolo Mannelli; Kathleen S Peindl; Tong Lee; Kamal S Bhatia; Li-Tzy Wu
Journal:  Curr Drug Abuse Rev       Date:  2012-03

Review 2.  Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence.

Authors:  Sofie Mauger; Ronald Fraser; Kathryn Gill
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-07       Impact factor: 2.570

3.  Electronic health records: essential tools in integrating substance abuse treatment with primary care.

Authors:  Betty Tai; Li-Tzy Wu; H Westley Clark
Journal:  Subst Abuse Rehabil       Date:  2012-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.